GlassScriptPhysician profile
John Dryden
NPI 1275971699
$1,153.70
in general payments reported to CMS, 2019-2025
10 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $15.83 · 2023: $31.52 · 2024: $342 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $305.97 | 2021-2025 | Endurant Iis, Concertotm |
| Boston Scientific Corporation | $241.40 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, General - Vascular Intervention |
| Terumo Medical Corporation | $206.14 | 2025 | Azur Cx Detachable, Angio-Seal, Navicross |
| Penumbra, INC. | $139.48 | 2025 | Ruby Coil, Indigo System |
| Cardiva Medical, INC. | $124.14 | 2022-2024 | Optowire, Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Canon Medical Systems USA, INC. | $61.22 | 2024 | Interventional Angiography System |
| Ecs Opco 1 LLC | $21.12 | 2024 | Bioflo, Cook Spectrum |
| Argon Medical Devices, INC. | $18.87 | 2025 | Clot Management |
| Balt USA, LLC | $18.49 | 2024 | Prestige Coil System |
| Chiesi USA, INC. | $16.87 | 2023 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dryden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.